Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00149552 · ClinicalTrials.gov registry record · NA
Zinc Therapy in HIV Infected Individuals Who Abuse Drugs
A NA study, sponsored by Florida International University.
- Completed
- Registry status
- NA
- Development phase
- 231
- Enrollment target
NCT00149552 is a NA study that has completed, run by Florida International University. The registered enrollment target is 231 participants.
The verdict
NCT00149552, a NA study, has completed, sponsored by Florida International University.
- COMPLETED
- Registry status
- NA
- Development phase
- 231 participants
- Enrollment target
Study Summary
Zinc deficiency is prevalent in HIV infected individuals who abuse drugs. The purpose of this study is to determine if zinc therapy will prevent immune failure in HIV infected individuals who abuse drugs and have low plasma zinc levels.
Interventions
- DIETARY_SUPPLEMENT zinc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2001-06 |
| Est. Completion | 2007-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00149552
The ClinicalTrials.gov registry entry for NCT00149552 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 231 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida International University, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which zinc is the first listed.
NCT00149552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00149552 about?
NCT00149552 is a clinical study titled "Zinc Therapy in HIV Infected Individuals Who Abuse Drugs". Zinc deficiency is prevalent in HIV infected individuals who abuse drugs. The purpose of this study is to determine if zinc therapy will prevent immune failure in HIV infected individuals who abuse drugs and have low plasma zinc levels.
What is the current status of trial NCT00149552?
This trial is currently completed. It is a NA study. The enrollment target is 231 participants. The study started on 2001-06. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00149552?
The interventions under investigation include: zinc (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00149552?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.